APPLICATION OF COMPLEX IRON (III) COMPOUNDS FOR PRODUCTION OF MEDICINE FOR ORAL TREATMENT OF IRON DEFICIENCY CONDITIONS IN PATIENTS AFFECTING CHRONIC INFLAMMATORY DISEASES OF THE INTESTINE

摘要

1. The use of a complex compound of iron (III) with a carbohydrate for the manufacture of a medicament for oral treatment of iron deficiency conditions in patients suffering from chronic inflammatory bowel disease. ! 2. The use according to claim 1, in which the carbohydrate is selected from the group consisting of dextrans and hydrogenated dextrans, dextrins and hydrogenated or oxidized dextrins, as well as pullulan, its oligomers and hydrogenated pullulan. ! 3. The use according to claim 1, in which the carbohydrate is selected from oxidized or hydrogenated dextrins. ! 4. The use according to claim 1, in which the complex compound of iron (III) is a complex compound of iron (III) -polymaltose. ! 5. The use according to claim 4, in which the complex compound iron (III) -polymaltose has a molecular weight in the range from 20,000 to 500,000 D.! 6. The use according to claim 1, in which the complex compound of iron (III) is a complex compound of iron (III) with the oxidation product of one or more maltodextrins. ! 7. The use according to claim 6, in which the complex compound of iron (III) is a water-soluble iron-carbohydrate complex obtained from an aqueous solution of an iron (III) salt and an aqueous solution of the oxidation product of one or more maltodextrins with an aqueous solution of hypochlorite at a pH of alkaline region, and in which, if maltodextrin is used alone, then its dextrose equivalent is from 5 to 37; if a mixture of several maltodextrins is used, then the dextrose equivalent of the mixture is from 5 to 37, and the dextrose equivalent of the individual maltodextrins included in the mixture is from 2 to 40.! 8. The use according to claim 1, in which the drug